AdaptHealth Corp. (AHCO)
Total Valuation
AdaptHealth has a market cap or net worth of $994.28 million. The enterprise value is $3.24 billion.
| Market Cap | 994.28M |
| Enterprise Value | 3.24B |
Important Dates
The next estimated earnings date is Monday, February 26, 2024, after market close.
| Earnings Date | Feb 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 136.39 million shares outstanding. The number of shares has decreased by -1.89% in one year.
| Shares Outstanding | 136.39M |
| Shares Change (YoY) | -1.89% |
| Shares Change (QoQ) | -0.92% |
| Owned by Insiders (%) | 16.66% |
| Owned by Institutions (%) | 86.06% |
| Float | 73.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.03 |
| PS Ratio | 0.32 |
| Forward PS | 0.29 |
| PB Ratio | 0.57 |
| P/FCF Ratio | 32.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.83, with an EV/FCF ratio of 105.94.
| EV / Earnings | n/a |
| EV / Sales | 1.04 |
| EV / EBITDA | 28.83 |
| EV / EBIT | n/a |
| EV / FCF | 105.94 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 1.33.
| Current Ratio | 1.31 |
| Quick Ratio | 0.95 |
| Debt / Equity | 1.33 |
| Debt / EBITDA | 20.48 |
| Debt / FCF | 75.27 |
| Interest Coverage | -2.56 |
Financial Efficiency
Return on equity (ROE) is -20.80% and return on invested capital (ROIC) is -8.77%.
| Return on Equity (ROE) | -20.80% |
| Return on Assets (ROA) | -8.40% |
| Return on Capital (ROIC) | -8.77% |
| Revenue Per Employee | $286,443 |
| Profits Per Employee | -$39,172 |
| Employee Count | 10,900 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 22.52 |
Taxes
| Income Tax | -26.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.46% in the last 52 weeks. The beta is 1.05, so AdaptHealth's price volatility has been similar to the market average.
| Beta (1Y) | 1.05 |
| 52-Week Price Change | -62.46% |
| 50-Day Moving Average | 7.88 |
| 200-Day Moving Average | 10.53 |
| Relative Strength Index (RSI) | 43.77 |
| Average Volume (30 Days) | 1,304,509 |
Short Selling Information
The latest short interest is 8.78 million, so 6.43% of the outstanding shares have been sold short.
| Short Interest | 8.78M |
| Short Previous Month | 7.69M |
| Short % of Shares Out | 6.43% |
| Short % of Float | 12.00% |
| Short Ratio (days to cover) | 7.82 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.12 billion and -$426.98 million in losses. Loss per share was -$3.42.
| Revenue | 3.12B |
| Gross Profit | 400.62M |
| Operating Income | -353.87M |
| Pretax Income | -453.14M |
| Net Income | -426.98M |
| EBITDA | 112.41M |
| EBIT | -325.82M |
| Loss Per Share | -$3.42 |
Balance Sheet
The company has $56.14 million in cash and $2.30 billion in debt, giving a net cash position of -$2.25 billion or -$16.47 per share.
| Cash & Cash Equivalents | 56.14M |
| Total Debt | 2.30B |
| Net Cash | -2.25B |
| Net Cash Per Share | -$16.47 |
| Equity / Book Value | 1.73B |
| Book Value Per Share | 12.70 |
| Working Capital | 136.88M |
Cash Flow
In the last 12 months, operating cash flow was $422.32 million and capital expenditures -$391.73 million, giving a free cash flow of $30.59 million.
| Operating Cash Flow | 422.32M |
| Capital Expenditures | -391.73M |
| Free Cash Flow | 30.59M |
| FCF Per Share | $0.23 |
Margins
Gross margin is 12.83%, with operating and profit margins of -11.33% and -13.68%.
| Gross Margin | 12.83% |
| Operating Margin | -11.33% |
| Pretax Margin | -14.51% |
| Profit Margin | -13.68% |
| EBITDA Margin | 3.60% |
| EBIT Margin | -10.44% |
| FCF Margin | 0.98% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -42.94% |
| FCF Yield | 3.08% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.89% |
| Shareholder Yield | 1.89% |
Analyst Forecast
The average price target for AdaptHealth is $12.73, which is 74.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.73 |
| Price Target Difference | 74.62% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 11.32% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 0.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.55 |
| Piotroski F-Score | 4 |